Category: News from Asia-pacific
Delhi-Based Healthcare Fintech Startup Raises $1 M in Seed Funding Round
Delhi-based healthcare financing startup, LetsMD has raised $1 million a pre-series A funding round led by SRI Capital.
New Potential Immuno-Oncology Drug for Blood Cancer Received Orphan Drug Status
Chinese biotech, Maxinovel Pharma’s immuno-oncology drug candidate- MAX-40279 received Orphan Drug designation from the US FDA for the treatment of ...
First Japanese Company Shionogi Receives CARB-X Funding for New Antibiotics Development against Superbugs
KEY POINTS CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) founded by US government Agencies and Wellcome Trust, London funds companies to ...
AI-Based Software EyeArt™ in Smartphone Could Prevent Vision Loss in 90% Diabetic People
KEY POINTS One in five diabetic Indians is at risk of developing diabetic retinopathy, which can lead to blindness. Eyenuk’s ...
A Chinese Biotech Raises $90 M in Series A for CAR-T Cell Therapy Development
Shanghai-based biotech JW Therapeutics has raised $90 million in Series A funding round, led by Temasek, Sequoia Capital China, and ...
HDFC Backs MedGenome, Raises $40 Million in Series C Funding
DNA diagnostics firm, MedGenome has closed the Series C funding round at $40 million. The new investors HDFC Ltd, HDFC ...
Health-tech Startup LiveHealth Raises $1.1 Million in Seed Round
Pune-based health-tech startup, LiveHealth has raised $1.1 million from Nexus Venture Partners in the seed round. LiveHealth works towards digitization ...
CNS Biopharma Suven Life Sciences Grabs Product Patents from India and South Korea
Hyderabad-based Suven Life Sciences has secured one product patent from India and one product patent from South Korea corresponding to ...
2018 is the Make or Break Year for Bugworks Research: CEO
Introduction Bangalore based Bugworks Research is a drug discovery start-up aims to develop powerful new antibiotics against the world’s deadliest superbugs. ...
3D Bioprinting Biotech Pandorum Raises $3.6 M, Aims to Reach Market
KEY POINTS Pandorum targets to bring innovation in tissue engineering and regenerative medicine space. Pandorum is Medgenera’s one of the ...